Analysis of the Contribution of CTL Epitopes in the Immunobiology of Morbillivirus Infection

• Published in: Virology (New York, N.Y.) N.Y.), 1996-05, Vol.219 (1), p.133-139
• Main Authors: BEAUVERGER, P., CARDOSO, A.I., DAVIET, L., BUCKLAND, R., WILD, T.F.
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Animals; Antigen Presentation - immunology; Base Sequence; Binding Sites; CD36 Antigens - genetics; CD36 Antigens - immunology; Cercopithecus aethiops; Distemper - immunology; Distemper - prevention & control; Distemper Virus, Canine - immunology; DNA, Viral; Dogs; Epitopes - genetics; Epitopes - immunology; Female; Humans; measles virus; Measles virus - immunology; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Nucleoproteins - genetics; Nucleoproteins - immunology; Recombinant Fusion Proteins - genetics; Recombinant Fusion Proteins - immunology; T-Lymphocytes, Cytotoxic - immunology; Tumor Cells, Cultured; Vaccines, Synthetic - administration & dosage; Vaccines, Synthetic - genetics; Vaccines, Synthetic - immunology; Vaccinia virus - genetics; Vero Cells; Viral Proteins - genetics; Viral Proteins - immunology; Viral Vaccines - administration & dosage; Viral Vaccines - genetics; Viral Vaccines - immunology
• ISSN: 0042-6822; 1096-0341
• DOI: 10.1006/viro.1996.0230

In Balb/c (H-2d) mice, the nucleoprotein (NP) of measles virus (MV) induces a MHC class I restricted-CTL response to a single 9-amino-acid epitope (aa 281–289). This Ld-restricted epitope is also present in the NP of the closely related canine distemper virus (CDV). To investigate whether this epitope is immunologically effective when it is present within the primary sequence of a nonviral protein, we have incorporated the 281–289 motif into the human CD36 protein. When cells are infected with vaccinia virus (VV) recombinants expressing this protein, CD36NP, the MV epitope is correctly processed and the cells are lysed by MVNP-specific CTLs.In vivo,VV-CD36NP induced CTLs which protected mice from a lethal dose of CDV, but did not block virus replication. The MVNP contains four other potential Ld-restricted motifs. To investigate if these could be utilized in the absence of the dominant epitope, a mutant NP was produced in which one of the anchor residues in the aa 281–289 motif was mutated. Cells infected with a VV recombinant expressing this protein (VV-NP F289S) were only poorly lysed by MVNP-specific CTLs. Similarly, immunization of Balb/c mice with VV-NP F289S induced a lower level of CTL activity compared to the VV-NP, but the activity was now directed to three other epitopes. When mice were vaccinated with VV-NP F289S they were only partially protected from a lethal CDV challenge. The significance of these results for MV vaccine development is discussed.